InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,598.40
(
1.03%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.48
(
0.42%
)
Bitcoin
63,465.40
(
-0.83%
)

Replies to post #3426 on Moleculin Biotech Inc (MBRX)

Replies to #3426 on Moleculin Biotech Inc (MBRX)

coffee2go

01/24/21 9:06 AM

#3427 RE: coffee2go #3426

Roth Capital analyst Jonathan Aschoff maintained a Buy rating on Moleculin Biotech (MBRX) on December 17 and set a price target of $5.00. The company’s shares closed last Thursday at $1.07.